These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26726791)

  • 21. "Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK.
    Corazza O; Simonato P; Corkery J; Trincas G; Schifano F
    Riv Psichiatr; 2014; 49(2):89-94. PubMed ID: 24770577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand.
    Wilkins C
    Addiction; 2014 Oct; 109(10):1580-6. PubMed ID: 24529166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.
    Simonato P; Corazza O; Santonastaso P; Corkery J; Deluca P; Davey Z; Blaszko U; Schifano F
    Hum Psychopharmacol; 2013 Jul; 28(4):324-31. PubMed ID: 23881880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural product 'legal highs'.
    Arunotayanun W; Gibbons S
    Nat Prod Rep; 2012 Nov; 29(11):1304-16. PubMed ID: 22930322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.
    Corazza O; Assi S; Malekianragheb S; Beni MN; Bigdeli I; Aslanpour Z; Schifano F
    Int J Drug Policy; 2014 Jul; 25(4):724-6. PubMed ID: 24917190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New psychoactive substances legislation in Ireland - Perspectives from academia.
    Kavanagh PV; Power JD
    Drug Test Anal; 2014; 6(7-8):884-91. PubMed ID: 24478277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited use of novel psychoactive substances in South London nightclubs.
    Wood DM; Hunter L; Measham F; Dargan PI
    QJM; 2012 Oct; 105(10):959-64. PubMed ID: 22718853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interim regulated legal market for NPS ('legal high') products in New Zealand: The impact of new retail restrictions and product licensing.
    Wilkins C
    Drug Test Anal; 2014; 6(7-8):868-75. PubMed ID: 24817124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute kidney injury and critical limb ischaemia associated with the use of the so called "legal high" 3-fluorophenmetrazine.
    Fawzy M; Wong-Morrow WS; Beaumont A; Farmer CKT
    CEN Case Rep; 2017 Nov; 6(2):152-155. PubMed ID: 28711979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism].
    Wierzejska R
    Dev Period Med; 2014; 18(3):394-9. PubMed ID: 25182406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From divination to madness: features of acute intoxication with Salvia use.
    Winslow M; Mahendran R
    Singapore Med J; 2014 Apr; 55(4):e52-3. PubMed ID: 24763842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purchasing 'legal highs' on the Internet--is there consistency in what you get?
    Davies S; Wood DM; Smith G; Button J; Ramsey J; Archer R; Holt DW; Dargan PI
    QJM; 2010 Jul; 103(7):489-93. PubMed ID: 20413562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the recent ban on animal testing of legal high products a fatal blow to the development of a legal market for 'low-risk' psychoactive products in New Zealand?
    Rychert M; Wilkins C
    Addiction; 2015 Apr; 110(4):714-5. PubMed ID: 25771695
    [No Abstract]   [Full Text] [Related]  

  • 35. An investigation of the stability of emerging new psychoactive substances.
    Soh YN; Elliott S
    Drug Test Anal; 2014; 6(7-8):696-704. PubMed ID: 24573920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using poisons information service data to assess the acute harms associated with novel psychoactive substances.
    Wood DM; Hill SL; Thomas SH; Dargan PI
    Drug Test Anal; 2014; 6(7-8):850-60. PubMed ID: 24832864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances.
    Wood DM; Dargan PI
    Ther Drug Monit; 2012 Aug; 34(4):363-7. PubMed ID: 22673201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service.
    Kamour A; James D; Lupton DJ; Cooper G; Eddleston M; Vale A; Thompson JP; Thanacoody R; Hill SL; Thomas SH
    Clin Toxicol (Phila); 2014 Dec; 52(10):1025-31. PubMed ID: 25345418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methoxetamine--a novel recreational drug with potent hallucinogenic properties.
    Zawilska JB
    Toxicol Lett; 2014 Nov; 230(3):402-7. PubMed ID: 25128700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are "Legal Highs" users satisfied? Evidence from online customer comments.
    Bruneel CA; Lakhdar CB; Vaillant NG
    Subst Use Misuse; 2014 Mar; 49(4):364-73. PubMed ID: 24093527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.